Drug profile · INN
risdiplam
EVRYSDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
risdiplam (EVRYSDI) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN risdiplam
Brand EVRYSDI
Route ORAL
Formulation FOR SOLUTION
ATC code M09AX10
Originator Hoffmann-La Roche
Frequently asked questions
What is risdiplam?
risdiplam (EVRYSDI) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for risdiplam?
EVRYSDI is a marketed brand name for risdiplam. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of risdiplam?
risdiplam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.